Your browser doesn't support javascript.
loading
Structure Based Affinity Maturation and Characterizing of SARS-CoV Antibody CR3022 against SARS-CoV-2 by Computational and Experimental Approaches.
Yu, Wei; Zhong, Nan; Li, Xin; Ren, Jiayi; Wang, Yueming; Li, Chengming; Yao, Gui; Zhu, Rui; Wang, Xiaoli; Jia, Zhenxing; Wu, Changwen; Chen, Rongfeng; Zheng, Weihong; Liao, Huaxin; Wu, Xiaomin; Yuan, Xiaohui.
Affiliation
  • Yu W; Institute of Biomedicine, Jinan University, Guangzhou 510632, China.
  • Zhong N; Anhui Province Key Laboratory of Pollutant Sensitive Materials and Environmental Remediation, College of Life Sciences, Huaibei Normal University, Huaibei 235000, China.
  • Li X; Institute of Biomedicine, Jinan University, Guangzhou 510632, China.
  • Ren J; Guangdong Provincial Key Laboratory of Bioengineering Medicine, Guangzhou 510632, China.
  • Wang Y; Institute of Biomedicine, Jinan University, Guangzhou 510632, China.
  • Li C; National Engineering Research Center of Genetic Medicine, Guangzhou 510632, China.
  • Yao G; Institute of Biomedicine, Jinan University, Guangzhou 510632, China.
  • Zhu R; School of Health, Zhuhai College of Science and Technology, Zhuhai 519041, China.
  • Wang X; Institute of Biomedicine, Jinan University, Guangzhou 510632, China.
  • Jia Z; Zhuhai Trinomab Biotechnology Co., Ltd., Zhuhai 519040, China.
  • Wu C; Institute of Biomedicine, Jinan University, Guangzhou 510632, China.
  • Chen R; Zhuhai Trinomab Biotechnology Co., Ltd., Zhuhai 519040, China.
  • Zheng W; Anhui Province Key Laboratory of Pollutant Sensitive Materials and Environmental Remediation, College of Life Sciences, Huaibei Normal University, Huaibei 235000, China.
  • Liao H; Anhui Province Key Laboratory of Pollutant Sensitive Materials and Environmental Remediation, College of Life Sciences, Huaibei Normal University, Huaibei 235000, China.
  • Wu X; Zhuhai Trinomab Biotechnology Co., Ltd., Zhuhai 519040, China.
  • Yuan X; Zhuhai Trinomab Biotechnology Co., Ltd., Zhuhai 519040, China.
Viruses ; 14(2)2022 01 19.
Article in En | MEDLINE | ID: mdl-35215781

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Neutralizing / Molecular Dynamics Simulation / SARS-CoV-2 / Antibodies, Monoclonal / Antibody Affinity Type of study: Prognostic_studies Language: En Journal: Viruses Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Neutralizing / Molecular Dynamics Simulation / SARS-CoV-2 / Antibodies, Monoclonal / Antibody Affinity Type of study: Prognostic_studies Language: En Journal: Viruses Year: 2022 Document type: Article Affiliation country: Country of publication: